ETV4 and hepatocellular carcinoma: ETS variant 4 (ETV4) is overexpressed in patients with HBV-related HCC and can activate the pathway, which promotes the proliferation, invasion, and metastasis of HCC cells, leading to the progression of HBV-associated HCC (134).